Cardiology (all articles)
[Abstract Only] Randomized Trial: SGLT2 Inhibitor Improves Outcomes in Patients with Heart Failure Even in the Absence of Diabetes
20 Sep, 2019 | 08:27h | UTCDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine (link to abstract – $ for full-text)
Related 2019 ESC Congress News Release, Before Publication: Randomized Trial: SGLT2 inhibitors Seems Beneficial for Heart Failure Even in Nondiabetics (free commentaries)
Commentaries: SGLT2 Inhibitor Dapagliflozin Lowers Risk for Worsening Heart Failure – NEJM Journal Watch (free) AND New research shows dapagliflozin used to treat diabetes can also treat heart failure, in patients with and without diabetes (the DAPA-HF Study) – Diabetologia (free)
Cohort Study: Metformin Linked to Reduced Risk of Cardiovascular Events Compared to Sulfonylurea Among Patients with Diabetes and Reduced Kidney Function
20 Sep, 2019 | 08:19h | UTCAssociation of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function – JAMA (free for a limited period)
Commentaries: Metformin Superior for Lowering CV Risk in Diabetics Who Progress to CKD – Renal & Urology News (free) AND Metformin Monotherapy Benefits Heart Even in Early CKD – MedPage Today (free registration required)
Related Commentary on Twitter
Monotherapy treatment with #metformin, compared with a #sulfonylurea, was associated with a lower risk of MACE among patients with diabetes and reduced kidney function https://t.co/Z1EZAjOOET
— JAMA (@JAMA_current) September 19, 2019
Meta-Analysis: Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients
20 Sep, 2019 | 08:07h | UTCTranscatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Meta-Analysis of TAVR vs. SAVR in Low-Risk Patients – American College of Cardiology (free) AND TAVR Survival Surpasses SAVR in Low-Risk Patients: Meta-analysis – Medscape (free registration required)
“The one clear unknown that everyone points to is valve durability” (form Medscape)
“longer follow-up regarding valve degeneration will be needed to confirm TAVR as the preferred treatment for low-risk patients with severe AS.” (from American College of Cardiology)
[Abstract Only] Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population
19 Sep, 2019 | 08:19h | UTCPolypill for Cardiovascular Disease Prevention in an Underserved Population – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population – TCTMD (free) AND One daily combo pill helps lower heart disease risk in study of underserved patients – American Heart Association (free) AND Fixed Dose Combination Polypill Can Reduce Barriers to Cardiovascular Care – MedicalResearch.com (free) AND One pill with four drugs may lower heart risks in poor population – Reuters (free) AND All-in-One Pill Reduces Blood Pressure, Cholesterol Levels in U.S. Study – Vanderbilt University Medical Center (free)
Related Randomized Trial: Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases (link to abstract and commentaries)
See also: Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology – Global Heart (free) AND Perspective: The Polypill and the Long Journey to Major Impact (opinion and reviews on the subject) AND Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care (free commentaries)
[Abstract Only] Study: Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Disease
18 Sep, 2019 | 08:36h | UTCPersonalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit–Harm Analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Aspirin may benefit some people without cardiovascular disease, new analysis finds – ACP Internist (free) AND Some Adults Without Heart Disease May Benefit From Aspirin – MedicalResearch.com (free) AND Expert reaction to study looking at benefits and harms of aspirin in people without cardiovascular disease – Science Media Centre (free)
[Abstract Only] Cohort Study: Complete vs. Staged Repair of Tetralogy of Fallot in Neonates
18 Sep, 2019 | 01:06h | UTCComplete vs. Staged Repair of Tetralogy of Fallot in Neonates – American College of Cardiology (free)
Original Study: 2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Scientific Statement: Review of Current Evidence and Clinical Recommendations on the Effects of Low-carbohydrate and Very-low-carbohydrate (Including Ketogenic) Diets for the Management of Body Weight and Other Cardiometabolic Risk Factors
17 Sep, 2019 | 07:25h | UTC
Cohort Study: Lower Carbohydrate Diets and All-cause and Cause-specific Mortality
17 Sep, 2019 | 07:19h | UTCCommentary: Lower Carbohydrate Diets, All-Cause and Cause-Specific Mortality – American College of Cardiology (free)
EHRA/EAPCI Expert Consensus Statement on Catheter-based Left Atrial Appendage Occlusion
17 Sep, 2019 | 01:08h | UTC
ACC Consensus Decision Pathway for Heart Failure Hospitalizations
16 Sep, 2019 | 02:24h | UTCKey Points to Remember: ACC Consensus Decision Pathway for Heart Failure Hospitalizations – American College of Cardiology (free)
[Abstract Only] Study: High Prevalence of Obstructive Sleep Apnea in Patients with Resistant Hypertension
16 Sep, 2019 | 02:18h | UTCPrevalence, Characteristics and Association of Obstructive Sleep Apnea with Blood Pressure Control in Patients with Resistant Hypertension – Annals of the American Thoracic Society (link to abstract – $ for full-text)
Commentaries: Most patients with resistant hypertension have sleep apnoea – OnMedica (free) AND More Severe OSA Leads to Higher Blood Pressure in Patients with Resistant Hypertension – American Thoracic Society (free) AND Obstructive Sleep Apnea Common in Patients with Resistant Hypertension – MedicalResearch.com (free)
ACE inhibitors and ARBs: Managing Potassium and Renal Function
16 Sep, 2019 | 02:14h | UTCEditorial: ACE inhibitor and ARB therapy: Practical recommendations (free)
Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience
16 Sep, 2019 | 02:13h | UTCCommentary: First-in-Human Telerobotic Coronary Intervention Procedures Published in EClinicalMedicine – Diagnostic and Interventional Cardiology (free)
Viewpoint: Redefining Heart Failure with a Reduced Ejection Fraction
15 Sep, 2019 | 23:46h | UTCRedefining Heart Failure With a Reduced Ejection Fraction – JAMA (free for a limited period)
Chest Radiograph Signs Suggestive of Pericardial Disease
13 Sep, 2019 | 08:14h | UTCChest Radiograph Signs Suggestive of Pericardial Disease – American College of Cardiology (free)
Review: Obstructive Sleep Apnea in Acute Coronary Syndrome
12 Sep, 2019 | 08:00h | UTCObstructive sleep apnoea in acute coronary syndrome – European Respiratory Review (free)
Related: Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy (free reviews) AND Positive airway pressure doesn’t reduce cardiovascular events and death in adults with sleep apnea (link to abstract and commentaries)
[Abstract Only] Study: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation
11 Sep, 2019 | 08:05h | UTCOral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Fluoroquinolones and Cardiac Valve Regurgitation Risk – American College of Cardiology (free) AND Commonly used antibiotics may lead to heart problems – University of British Columbia (free)
Related: Committee Recommends New Restrictions on the use of Fluoroquinolones (free report and commentaries) AND FDA Safety Alert: Warnings for Fluoroquinolones on Risks of Mental Health and Low Blood Sugar Adverse Reactions (free statement and commentaries) AND FDA Warns About Increased Risk of Aortic Dissection and Ruptures of Aortic Aneurism with Fluoroquinolones (free report and commentaries) AND Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study – Resuscitation (link to abstract – $ for full-text)
Hypertensive Crisis: Pearls and Pitfalls for the ED Physician
11 Sep, 2019 | 08:02h | UTCHypertensive Crisis: Pearls and Pitfalls for the ED Physician – emDocs (free)
Related: ESC Council on hypertension position document on the management of hypertensive emergencies – European Heart Journal – Cardiovascular Pharmacotherapy (free) AND 7th Brazilian Guideline of Arterial Hypertension: Chapter 14 – Hypertensive Crisis – Arquivos Brasileiros de Cardiologia (free) AND Focused Update on Pharmacologic Management of Hypertensive Emergencies – Current Hypertension Reports (free)
[Abstract Only] Cohort Study: Sleep Duration and Myocardial Infarction
11 Sep, 2019 | 00:01h | UTCSleep Duration and Myocardial Infarction – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Heart attack risk higher in those who sleep too little or too much – Medical News Today (free) AND Sleeping too much, too little may increase heart attack risk – UPI (free)
Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention
10 Sep, 2019 | 23:58h | UTC
[Abstract Only] Observational Study: Patients with Moderate Aortic Stenosis Have Poor Long-term Survival
10 Sep, 2019 | 23:55h | UTCPoor Long-Term Survival in Patients With Moderate Aortic Stenosis – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease – TCTMD (free) AND Poor Long-Term Survival in Moderate Aortic Stenosis Patients – American College of Cardiology (free)
[Abstract Only] Cohort Study: Outcomes with Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
10 Sep, 2019 | 01:30h | UTCAnticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Anticoagulation After Bioprosthetic Valve Replacement or TAVR – American College of Cardiology (free) AND Anticoagulation May Be Safe After Bioprosthetic Aortic Valve Replacement – Cardiology Advisor (free) AND Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II – TCTMD (free)
Review: Assessment and Treatment of Patients with Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury
9 Sep, 2019 | 00:03h | UTCRelated Reviews: A systematic review on the triggers and clinical features of type 2 myocardial infarction – Clinical Cardiology (free) AND Type 2 Myocardial Infarction: An Evolving Entity – Circulation Journal (free)
Occupational Cardiology Series: Cardiovascular Assessment of Aircrew and Other High-hazard Employees
9 Sep, 2019 | 00:01h | UTC
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
8 Sep, 2019 | 23:58h | UTCRelated: Cardiac Amyloidosis: Updates in Imaging (several reviews on the subject)